Business Health US & Canada

J&J Proposes $5.5bn Talc Settlement

J&J Proposes $5.5bn Talc Settlement

The $5.5 billion proposal aims to resolve over 60,000 claims from women who alleged that J&J's talc-based powders contained asbestos and caused ovarian cancer.

The company has consistently denied the allegations, but previous settlement attempts failed.

This new offer comes after a series of court setbacks and is structured to gain broad claimant support.

The deal would allow J&J to move past the litigation without admitting liability.

Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
United States
Country located primarily in North America
Ovarian cancer
Female reproductive organ cancer that is located in the ovary